CalciMedica, Inc.

Healthcare · Biotechnology · United States

Last price 1.46 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 9.97M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumati...